### Benefits and Side Effects of the New Topical Treatment for Eczema The U.S. FDA has approved Zoryve (roflumilast) cream 0.15% for treating mild to moderate atopic dermatitis, a common type of eczema, in adults and children aged 6 and older. This once-daily cream works quickly and has fewer side effects compared to other treatments. It can be used for any length of time, making it a versatile option for continuous treatment. #### Benefits - **Quick Relief:** Zoryve can improve itchiness as soon as 24 hours after use. - **Fewer Side Effects:** Unlike traditional treatments like topical steroids, Zoryve has minimal side effects, making it safer for long-term use. - **Versatile Application:** It can be applied anywhere on the skin, including sensitive areas like around the eyes. - **Non-Steroidal:** It doesn't rely on corticosteroids, reducing the risk of side effects associated with steroid use. #### Side Effects In clinical trials, less than 3% of participants experienced side effects. The most common ones were headache, nausea, pain at the application site, diarrhea, and vomiting. Overall, the data suggests that Zoryve is safe for long-term use. #### Availability and Cost Zoryve is expected to be available for purchase by the end of July. The cost will depend on your insurance coverage, but the manufacturer offers programs to help reduce out-of-pocket expenses. #### Conclusion Zoryve offers a new, effective, and safer option for treating atopic dermatitis, especially for those who need long-term treatment. Consult your healthcare provider to see if this new treatment is right for you.